Login / Signup

Cenobamate: real-world data from a retrospective multicenter study.

Stephan LauxmannDavid HeuerJan HeckelmannFlorian P FischerMelanie SchreiberElisabeth SchriewerGuido WidmanYvonne WeberHolger LercheMichael AlberSigrid Schuh-HoferStefan Wolking
Published in: Journal of neurology (2024)
Adjunctive cenobamate was not associated with clinically significant changes in weight from baseline in patients treated for 1 and 2 years, including those receiving concomitant valproate, gabapentin, or pregabalin.
Keyphrases
  • neuropathic pain
  • electronic health record
  • body mass index
  • spinal cord
  • weight loss
  • physical activity
  • spinal cord injury
  • big data
  • weight gain
  • postoperative pain
  • artificial intelligence